You are browsing the Hong Kong website, Regulated by Hong Kong SFC (CE number: BJA907). Investment is risky and you must be cautious when entering the market.
药明康德(02359.HK)拟根据特别授权配售6820.54万股 融资约73.7亿港元
格隆汇 07-29 06:17

格隆汇7月29日丨药明康德(02359.HK)发布公告,2020年7月29日(交易时间前),公司与Morgan Stanley & Co. International Plc、华泰金融控股(香港)有限公司、高盛(亚洲)有限责任公司及 J.P. Morgan Securities Plc(统称“配售代理”)订立配售协议,据此,公司同意委任配售代理而配售代理各自同意(而非共同,亦非共同及个别)出任公司代理,并尽力促使若干承配人按照配售协议所载条款及条件,按每股配售股份108.0港元合共认购公司根据特别授权将发行的6820.54万股新H股。

配售股份数目分别占截至该公告日期现有已发行H股总数及现有已发行股份总数约28.57%及2.95%;及紧随完成后经发行配售股份扩大后的已发行H股总数及已发行股份总数约22.22%及2.87%。配售价每股配售股份108.0港元较7月28日收市价每股H股113.90港元折让约5.2%。

假设所有配售股份获悉数认购,配售所得款项总额预期将约为73.7亿港元。配售的募集资金净额预计约为72.9亿港元(按每股配售股份净价约106.95港元计算)。其中,约35.0%用于并购,包括但不限于扩展集团于美国、欧洲及亚太区的业务;约20.0%用于扩展集团海外业务;约15.0%用于建设常熟研发一体化项目;约10.0%用于偿还银行贷款及其他借款;及剩余金额用于补充公司的营运资金。

配售股份预期将配售予不少于六名独立承配人(须为专业、机构及其他投资者)。配售股份将根据特别授权发行。配售毋须股东另行批准。公司将向香港联交所上市委员会申请批准配售股份上市及买卖。

Follow us
Find us on Facebook, Twitter , Instagram, and YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!
Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.
uSMART
Wealth Growth Made Easy
Open Account